Introduction
The eye manifestations of Graves' disease are defined in 2 distinct categories: mild or noninfiltrative and severe or infiltrative (Werner, 1961) . In the non-infiltrative variety, the common eye changes are prominent staring eyes, proptosis, wide palpebral fissure and lid retraction; while the infiltrative type is characterized by excessive lacrimation, grittiness, chemosis, decreased resilience of eye balls, ophthalmoplegias and fundal changes. Sudden or progressive visual failure due to corneal ulceration, corneal oedema and infiltration, papilloedema and optic atrophy may also be seen. Such cases are rare and usually the ophthalmic manifestations of Graves' disease are a self-limiting process (Brain, 1959) .
Clinical features
For the purpose of this article, the clinical cases have been classified into 3 groups: where visual failure was due to -oedema and infiltration, A; involvement of the optic nerve, B; a combination of factors, C.
The clinical profile of 14 patients is given in (Leading Article, 1968) .
In 1825, the descriptions of 8 cases of exophthalmic goitre were found among the posthumous writings of Caleb Hillier Parry. Graves described it in 1835 while Basedow described its ophthalmic features in 1840 (Leading Article, 1968 (Havard, 1972) , but most of these do not signify the true nature of the underlying pathology (Taylor, 1960) . The term 'congestive ophthalmopathy' is preferred as the lids and conjunctivae are invariably congested and oedema is a frequent feature. The American Thyroid Association (Werner, 1969) have adopted a classification where the 'mild' end of the spectrum is represented by class 1 and the 'severe' end by classes 2-6. Since eye changes may persist after the disease process has subsided, the terms 'active' and 'inactive' are added.
The clinical impression which persisted for over a century was that the ocular manifestations are of purely hyperthyroid origin and occur only with Graves' disease. Over the last 2 decades, however, clinical and experimental studies have shown that the progressive eye changes can appear in euthyroid and hypothyroid state; and may even begin before there is any evidence of thyroid dysfunction (Werner and Ingbar, 1971 development of hypothyroidism may be the significant factor. Thus, rapid treatment tends to worsen the ocular manifestations (Aranow and Day, 1965) . In some patients, the eye changes were aggravated by thyroid surgery although no definite time relationship was noticed. The incidence of progressive eye changes following subtotal thyroidectomy has been reported as 3 to 7/o while following radioiodine therapy it is said to be approximately 5/o (Sloan, 1951; Hamilton et al., 1967) . Zimmerman (1929) and Thomas and Woods (1936) have described many cases with progressive ocular changes which were initiated by partial thyroidectomy.
The course of exophthalmos and other eye changes is variable and unpredictable (Havard, 1972 (Winand, 1968; Pisarev, Altschuler and Davison (1968 (Poppen, 1953) . The levator palpebrae superioris muscle is not stretched by the rise of intra-orbital tension and is rarely paralysed. This is attributed to the fact that its anterior insertion in the upper lid is mobile, not fixed. As the process advances, the affected muscles become fibrotic and short, leading to a fixed strabismus. The inferior rectus is the muscle which is most commonly involved. Bilateral shortening of this muscle accounts for the limitation in the upward movement commonly seen in clinical practice. With extensive muscle involvement the globe may be virtually immobile and the eyes are usually fixed in a downward squint. Very rarely the eye may be fixed in other positions. With increased intra-ocular pressure and overfilling of the orbit, the eyes become congested and the conjunctiva is glossy and waterlogged. Later it is thrown into folds along the free border of the lower lid. Subconjunctival haemorrhage and even glaucoma may result. The vision may fail from errors of refraction, corneal complications or optic nerve involvements. The optic nerve may be affected in the absence of severe proptosis. Increased intra-ocular pressure with resultant elevated pressure at the apex of the cone interferes with the blood supply of the optic nerve resulting in optic atrophy and irreversible visual loss. Poppen (1953) observed that increased tissue bulk confined in the region of the annulus of Zinn, where there was not enough fat to allow selfdecompression by fat absorption, resulted in pressure on the optic nerve, compromising its blood supply. Thus, in a patient who already has vascular disease, the vascular change could easily be precipitated. The visual prognosis in older patients and in those with arterial disease such as atherosclerosis and diabetes mellitus is, therefore, poor (Day and Carroll, 1962) .
Treatment
Therapy is empirical and the main aim is to prevent corneal ulceration and optic nerve involvement. Simple lubrication drops such as 0-5y/. methyl cellulose, and opthalmic ointments may be used to help prevent drying. Eye pads with paraffin gauze dressings over the closed eyelids may be applied at night if there is incomplete closure of the eyelids. Antibiotics may be used locally for infection. Guanethidine drops (Crombie and Lawson, 1967) of 5%/O solution may be used to relieve eyelid retraction. Subconjunctival or retrobulbar injections of methylprednisolone had not given very encouraging results (Garber, 1966) . Systemic steroid therapy has proved useful and sometimes in serious cases where the optic nerve is involved or corneal complications threaten, high doses of steroids given for a short period (prednisone 120 to 140 mg daily for 7 days and gradually tapered off) may bring about the desired results (Werner, 1966) .
Glucocorticosteroids depress mucopolysaccharide synthesis and have a suppressive effect on the immune cells. Diuretics mobilize and promote the excretion of salt and water retained by the hydrophilic mucopolysaccharides and are useful. The role of immunosuppressive therapy is doubtful (Werner and Platman, 1965) . Orbital decompression is undertaken when steroids are ineffective or contraindicated owing to systemic or local conditions. It is also advised when there is marked papilloedema, macular oedema or pressure on ciliary arteries manifesting as diminished visual acuity, field loss and marked increase in intra-ocular pressure. Classically, orbital decompression involves the removal of either the lateral wall or the roof of the orbit. More recently a transantral approach has been reported as giving good results (Ogura, Wessler and Avioli, 1971) . By this method, the lateral wall of the ethmoidal sinuses and the roof of the maxillary sinus are removed. Surgical interference is not likely to benefit ocular movements as the muscle involvement is due to local infiltration of the muscle itself. An appropriate muscle resection and myectomy may help in a non-progressive phase. Radiotherapy to the pituitary, or hypophysectomy are no longer recommended. External irradiation of the orbital tissue is considered useful although its evaluation needs confirmation. Donaldson and Bagshaw (1972) have reported rapid and beneficial effects by highly collimated supravoltage radiation of the retro-orbital space. Ravin, Sisson and Knapp (1975) advise that orbital radiotherapy should be considered as an initial therapeutic approach to the optic neuropathy of Graves' disease. Treatment of a hypermetabolic state should be properly monitored and gradual progress in a hyperthyroid condition should be ensured to avoid hypothyroidism. In fact, the patient may even be allowed to be mildly hyperthyroid until eye complications terminate spontaneously or with treatment.
Conclusion
Corneal oedema and infiltration, ophthalmoplegia and optic nerve involvement are the usual factors responsible for the heterogeneity of visual failure in Graves' disease. Usually more than one factor is responsible. The integrity of the cornea must be maintained with local antibiotics, large central tarsorrhaphy, orbital decompression (lateral or transfrontal), and steroids. With treatment, corneal infiltration may improve, visual acuity increase but proptosis, lid retraction and ophthalmoplegia usually persist. When the treatment is delayed, visual failure may lead to total blindness. A close and co-ordinated team approach by an endocrinologist and ophthalmologist is desirable for an effective treatment of ophthalmopathy.
